<SEC-DOCUMENT>0001193125-19-034106.txt : 20190211
<SEC-HEADER>0001193125-19-034106.hdr.sgml : 20190211
<ACCEPTANCE-DATETIME>20190211165603
ACCESSION NUMBER:		0001193125-19-034106
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20190211
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190211
DATE AS OF CHANGE:		20190211

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CONMED CORP
		CENTRAL INDEX KEY:			0000816956
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				160977505
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-16093
		FILM NUMBER:		19586244

	BUSINESS ADDRESS:	
		STREET 1:		525 FRENCH ROAD
		CITY:			UTICA
		STATE:			NY
		ZIP:			13502
		BUSINESS PHONE:		315-624-3208

	MAIL ADDRESS:	
		STREET 1:		525 FRENCH ROAD
		CITY:			UTICA
		STATE:			NY
		ZIP:			13502
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d686644d8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML><HEAD>
<TITLE>8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">8-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT
REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant to Section&nbsp;13 or 15(d) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): February&nbsp;11, 2019 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>CONMED CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>New York</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">0-16093</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">16-0977505</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other Jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of Incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>525 French Road</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Utica, New York</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>13502</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of Principal Executive Offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code: (315)
<FONT STYLE="white-space:nowrap">797-8375</FONT> </B></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former name or former address if changed since last report.) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <FONT STYLE="white-space:nowrap">8-K</FONT> filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting material pursuant to Rule <FONT STYLE="white-space:nowrap">14a-12</FONT> under the Exchange Act (17
CFR <FONT STYLE="white-space:nowrap">240.14a-12)</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT
STYLE="white-space:nowrap">14d-2(b)</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.14d-2(b))</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT
STYLE="white-space:nowrap">13e-4(c)</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.13e-4(c))</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this
chapter) or Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Securities Exchange Act of 1934 <FONT STYLE="white-space:nowrap">(&#167;240.12b-2</FONT> of this chapter). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange
Act.&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;2.01</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Completion of Acquisition or Disposition of Assets. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;11, 2019, CONMED Corporation, a New York corporation (&#147;CONMED&#148;), completed its previously announced acquisition (the
&#147;Acquisition&#148;) of all of the issued and outstanding common stock of Palmerton Holdings, Inc., a New York corporation (&#147;PHI&#148;), and all of the issued and outstanding equity securities of Buffalo Filter LLC, a Delaware limited
liability company (&#147;BF LLC&#148; and, together with PHI, the &#147;Acquired Companies&#148;), from Filtration Group FGC LLC, a Delaware limited liability company (&#147;Filtration Group&#148;), pursuant to the Securities Purchase Agreement (the
&#147;Securities Purchase Agreement&#148;), dated as of December&nbsp;13, 2018, by and between CONMED and Filtration Group. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to
the Securities Purchase Agreement, CONMED paid Filtration Group an aggregate purchase price of $365&nbsp;million in cash, as adjusted and payable pursuant to the Securities Purchase Agreement (the &#147;Purchase Price&#148;), upon the closing of the
Acquisition (the &#147;Closing&#148;). The adjustments to the Purchase Price include, among others, (i)&nbsp;a working capital adjustment, (ii)&nbsp;an upward adjustment for certain cash held by Filtration Group at the Closing, and (iii)&nbsp;a
downward adjustment for the amount of indebtedness of the Acquired Companies, expenses related to the transaction and other related fees and expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Securities Purchase Agreement and the transactions contemplated thereby does not purport to be complete and
is subject to, and qualified in its entirety by, the full text of the Securities Purchase Agreement, a copy of which was filed as Exhibit 10.1 to CONMED&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on
December&nbsp;14, 2018 and incorporated herein by reference. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;2.03</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Creation of a Direct Financial Obligation or an Obligation under an
<FONT STYLE="white-space:nowrap">Off-Balance</FONT> Sheet Arrangement of a Registrant. </B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the
Acquisition, on February&nbsp;11, 2019, CONMED borrowed $115.0&nbsp;million under the delayed draw term loan facility available to it under its sixth amended and restated credit agreement that was entered into on February&nbsp;7, 2019 and filed as
Exhibit 10.1 to CONMED&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on February&nbsp;7, 2019. The proceeds of the loans were used, together with a portion of the proceeds of CONMED&#146;s 2.625%
Convertible Senior Notes due 2024 that were issued on January&nbsp;29, 2019, borrowings under the revolving credit facilities available to CONMED under the credit agreement and cash on hand, to pay the purchase price for the Acquisition, to pay
related fees and expenses and to repay prior borrowings. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;8.01</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Other Events. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A copy of the press release issued by CONMED on February&nbsp;11, 2019 announcing that CONMED has completed the Acquisition is attached hereto
as Exhibit 99.1. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Financial Statements and Exhibits. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Financial statements of businesses acquired</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financial statements of the Acquired Companies required by Item&nbsp;9.01(a) of Form <FONT STYLE="white-space:nowrap">8-K</FONT> will be
filed by an amendment to this Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> no later than 71 calendar days after the date on which this Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> is required to be filed.
</P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Pro forma financial information</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The pro forma financial information required by Item&nbsp;9.01(b) of Form <FONT STYLE="white-space:nowrap">8-K</FONT> will be filed by an
amendment to this Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> no later than 71 calendar days after the date on which this Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> is required to be filed. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Exhibits</U> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit&nbsp;No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Description of Exhibit</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d686644dex991.htm">Press Release, dated February&nbsp;11, 2019, issued by CONMED Corporation. </A></TD></TR>
</TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">CONMED CORPORATION</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">(Registrant)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Daniel S. Jonas</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Daniel S. Jonas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Executive Vice President &#150; Legal Affairs, General Counsel&nbsp;&amp; Secretary</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: February&nbsp;11, 2019 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d686644dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g686644g70g72.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>NEWS RELEASE</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman"><B>CONTACT</B>:</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman"><B><I>CONMED Corporation</I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman"><B>Todd Garner</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman"><B>Chief Financial Officer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">315-624-3317</FONT></FONT></B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman"><B>ToddGarner@conmed.com</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONMED Completes Acquisition of Buffalo Filter LLC </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Utica, New York, February</B><B></B><B>&nbsp;11, 2019 &#150; CONMED Corporation (NASDAQ: CNMD)</B> today announced that it has completed its previously
announced acquisition of privately-held Buffalo Filter LLC (Buffalo Filter) from Filtration Group. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Buffalo Filter is the market leader in surgical smoke
evacuation technologies. The company&#146;s comprehensive product portfolio includes smoke evacuation pencils, smoke evacuators, and laparoscopic solutions. The original announcement of the acquisition and related presentation can be found on the
Investor Relations section of the Company&#146;s website at <U>www.conmed.com</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction is being financed through a combination of the net
proceeds of the Company&#146;s new 2.625% convertible notes, which were issued on January&nbsp;29, 2019, borrowings under the Company&#146;s amended and restated credit facility, and cash on hand. The Company plans to provide additional guidance
regarding the impact of the transaction on 2019 financial results when it reports first quarter financial results in late April. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About CONMED
Corporation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company&#146;s
products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery and gastroenterology. CONMED has a direct selling presence in 19 countries, and
international sales constitute approximately 50% of the Company&#146;s total sales. Headquartered in Utica, New York, the Company employs approximately 3,100 people. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Buffalo Filter </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For over 25 years, Buffalo Filter
has been a globally recognized brand in surgical safety. Dedication to improving healthcare safety and a strong commitment to quality, inspired the launch of cutting-edge innovations in surgical smoke evacuation and laparoscopic surgery solutions.
Buffalo Filter&#146;s world-renowned education program has changed the way the global healthcare community sees surgical smoke. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Forward-Looking Information </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains certain forward-looking statements (including &#147;forward-looking statements&#148; within the meaning of the U.S. Private
Securities Litigation Reform Act of 1995) with respect to the financial condition, results of operations and business of CONMED and certain plans and objectives of CONMED. All statements other than statements of historical or current fact included
in this press release are statements that could be deemed forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as &#147;plans,&#148; &#147;expects,&#148; &#147;expected,&#148;
&#147;scheduled,&#148; &#147;estimates,&#148; &#147;intends,&#148; &#147;anticipates&#148; or &#147;believes,&#148; or variations of such words and phrases, or can state that certain actions, events, conditions, circumstances or results
&#147;may,&#148; &#147;could,&#148; &#147;would,&#148; &#147;might&#148; or &#147;will&#148; be taken, occur or be achieved. These forward-looking statements are based upon the current beliefs and expectations of CONMED, members of its senior
management team and its Board of Directors, and are subject to significant risks and uncertainties, including factors outside of CONMED&#146;s control. Such risks and uncertainties contained in forward-looking statements can include, without
limitation: prospective performance and opportunities and the outlook for CONMED&#146;s and Buffalo Filter&#146;s businesses; the ability of CONMED to advance Buffalo Filter&#146;s product lines following the transaction; the potential effects of
the transaction on relationships with employees, customers, other business partners or governmental entities; the state of the credit markets generally and the availability of financing; other business effects, including the effects of industry,
economic or political conditions outside of CONMED&#146;s control; any assumptions underlying any of the foregoing; and other risks and uncertainties which may be detailed from time to time in reports filed by CONMED with the Securities and Exchange
Commission. CONMED&#146;s shareholders and other investors are cautioned that any such forward-looking statements are not guarantees of future performance and to not place undue reliance on these forward-looking statements, as actual results may
differ materially from those currently anticipated. All forward-looking statements are based on information currently available to CONMED, and CONMED undertakes no obligation to update any such forward-looking statements as a result of new
information, future developments or otherwise, except as expressly required by law. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g686644g70g72.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g686644g70g72.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M 'FQC_EHOYT *)$)P'7\Z '4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0!!>\6%Q_US;^5 'P=]LNO^?F7_OLT 'VRZ_Y^9?\ OLT 'VRZ
M/ N)?^^S0!VVC> =:N=).N:]J1T'15Y^T7;-OD]HX^K'TH R=2\0V=H7MO#D
M=Q'%C:UY=2;IY!T.!]V,'VY]Z $\#75PWCS05:>0@WT607/]X4 ?;- 'D?B_
MXDZSJ7B9O!_@"!+C4E)6XO& *08ZXSQQW)[\ $T 54^"VOZD@GUWQ]J$EX>2
M(BQ5?898?R% #8/#_P 1_A_J]G+::W)K^AR3I'/%-EWC0L!NP22,9ZJ?J,4
M>P7M]::;:O<WMS%;6Z<M)*X51^)H Y=/BIX%DN/(7Q-9!\XRS$+_ -]$8_6@
M#J[>Y@N[=)[::.:%QE7C8,K#V(H K:7K%AK5O)-I]RDR12-%(!U1U."I'8T
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M'?W[4 :5 !0!!??\>%S_ -<F_E0!\.^&_#NH>*M>MM(TV/?/,W4_=1>['V%
M'V)X*\$Z5X'T5+'3H@96 ,]PP^>9O4^WH.U 'F_[2-O>R>'-(FB5C917#>=C
MH&*_*3_X\/QH ^;: +-CIU[J=TMK86LUS.W CB0L3^ H ]Q^&WP-U6VU2RUW
MQ%,+(6TBS16B$-(Q!R-QZ*/;D_2@#VKQ?H[^(/!^K:3&<275LZ(?]K''ZXH
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M[^YFE'DR'$=W&8E4 ^A!!PWX'B@#L=,B>WTFSAD7:\<**P]"% H M4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
%!0!__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
